LUNG Q2 2025 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+14.8% YoY

Gross Profit

$17M72.1% margin

Operating Income

-$15M-62.0% margin

Net Income

-$15M-63.6% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+5.9%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$147M

Total Liabilities

$78M

Stockholders' Equity

$69M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$21M	+14.8%
Gross Profit	$17M	$15M	+12.4%
Operating Income	-$15M	-$16M	+5.2%
Net Income	-$15M	-$15M	+1.0%

Geographic Segments

UNITED STATES

$15M62%

EMEA

$7M29%

Asia Pacific

$2M8%

Other International Geographical Areas

$102,0000%